Tech Startup Market Slows Amid Silicon Valley’s Doubts on Trump

The post-election rally that’s lifting U.S. public markets has left at least one group by the wayside: private technology startups. Since last year’s peak in mid-December, startup deal-making has fallen 37 percent, according to the Bloomberg U.S. Startups Barometer, which tracks fundraising, initial public offerings and acquisitions.

Uber Criticized by Venture Backers Over Harassment Claims

A pair of venture capital investors in Uber Technologies Inc. criticized the company for tapping insiders to conduct an investigation into sexual harassment and discrimination claims by a former employee. Mitch and Freada Kapor, spouses and investing partners at Kapor Capital, said they have been unsuccessful in their attempts to convince Uber behind the scenes to prioritize diversity issues.

Uber Criticized by Venture Backers Over Harassment Claims

A pair of venture capital investors in Uber Technologies Inc. criticized the company for tapping insiders to conduct an investigation into sexual harassment and discrimination claims by a former employee. Mitch and Freada Kapor, spouses and investing partners at Kapor Capital, said they have been unsuccessful in their attempts to convince Uber behind the scenes to prioritize diversity issues.

Sequoia-Backed China Robot Startup Said to Be Raising New Funds

Makeblock Co., a Chinese maker of DIY robotics parts, is seeking to raise funding at a $200 million valuation as the Sequoia Capital-backed startup expands into classrooms and hobbyist’s workshops globally, people familiar with the matter said. The Shenzhen-based company us seeking to raise about 200 million yuan in a series B round, the people said, requesting not to be named discussing a private matter.

Sequoia-Backed China Robot Startup Said to Be Raising New Funds

Makeblock Co., a Chinese maker of DIY robotics parts, is seeking to raise funding at a $200 million valuation as the Sequoia Capital-backed startup expands into classrooms and hobbyist’s workshops globally, people familiar with the matter said. The Shenzhen-based company us seeking to raise about 200 million yuan in a series B round, the people said, requesting not to be named discussing a private matter.

Stada Bid War Unfolds as Third Suitor Offers $3.84 Billion

Stada Arzneimittel AG is weighing offers as a bidding war for one of the last remaining generic-drug businesses of its size in Germany and Russia begins to unfold. The company said Thursday it received interest from a third firm that made a non-binding offer of 58 euros a share, or about 3.61 billion euros .

Tech Investor Jackson to Drop Activism With New Fund

Eric Jackson, an outspoken investor whose barbs have targeted Apple Inc., Yahoo! Inc. and Viacom Inc., plans to turn his back on activism to start a new hedge fund. Jackson left as managing director at SpringOwl Asset Management LLC in December and plans to launch the as yet unnamed new fund in the middle of this year, he said.

Startup funding drops in 2016

U.S. one dollar bills are arranged for a photograph in New York, U.S., on Thursday, Feb. 26, 2009. Less money flowed to Silicon Valley startups in 2016, after a period of frenzied spending the year before.

U.S. Money and Local Talent the Growth Plan for European Biotech

For a 28-year-old biotech entrepreneur, Frenchman Xavier Duportet has a standout resume: a PhD in biology and genome engineering from MIT, a lab at Paris’s Louis Pasteur Institute, and award-winning research with his name on it. Still, in Paris, as in capitals across Europe, it’s much harder for him to raise money than for most of his tech peers.

Silicon Valley Cash Is Still Chasing Blood Despite Theranos Bust

Amid the collapse of Theranos Inc. last year, investors are betting that some of the disgraced blood-testing startup’s lofty medical goals might still have a kernel of promise — at other companies. Grail, a company backed by Bill Gates and Jeff Bezos, said on Thursday that it’s expecting to raise a record $1 billion on the promise of a blood test to detect early-stage cancer.